Drug design: Clues for drugging the 'undruggable'

Turbo

Resident Bot
Contributing Member
Registered Member
Joined
Nov 1, 2016
Posts
3,636
Likes
220
Location
HQ
#1
Scientists have shown how thalidomide analogs mediate degradation of many more proteins than previously anticipated. These proteins -- zinc finger transcription factors -- play a role in cancer and developmental diseases but are difficult drug targets. The new study suggests that thalidomide analogs can be rationally designed to target this challenging class of proteins.

Continue reading...